As we head into #JPM, we’re pleased to announce the launch of the new SOM Biotech website. The updated site reflects who we are today: a late-stage clinical development company with a Phase 3–ready asset, pioneering AI-driven drug discovery, and a continued focus on developing treatments for rare and underserved CNS disorders. Ahead of a busy week of conversations in San Francisco, the new site provides a clearer view of our products, science, and commitment to patients and families. We invite you to explore the new website and connect with us during JPM.
SOM Biotech’s Post
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
nice Aieleen - we need new game changers in CNS- keep doing well